US SB4348 | 2021-2022 | 117th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on May 26 2022 - 25% progression, died in chamber
Action: 2022-07-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022

Sponsors


History

DateChamberAction
2022-07-13SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 444.
2022-07-13SenateCommittee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.
2022-06-14SenateCommittee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
2022-05-26SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB7035 (Related) 2022-03-10 - Referred to the Subcommittee on Health.
HB7640 (Related) 2022-05-03 - Referred to the House Committee on Energy and Commerce.
HB7658 (Related) 2022-05-03 - Referred to the House Committee on Energy and Commerce.
HB7679 (Related) 2022-05-06 - Referred to the House Committee on Energy and Commerce.
SB2628 (Related) 2021-08-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB2952 (Related) 2021-10-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4152 (Related) 2022-05-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4288 (Related) 2022-05-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4302 (Related) 2022-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
SB4303 (Related) 2022-05-25 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
SB4378 (Related) 2022-06-13 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4446 (Related) 2022-06-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S3077-3078)
SB4535 (Related) 2022-07-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB5002 (Related) 2022-09-29 - Held at the desk.
HB9329 (Related) 2022-11-18 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback